Comparable Outcome after Busulfan- or Treosulfan-Based Conditioning Regimen in Children Above 4 Years of Age with ALL Undergoing Allogeneic HSCT. Results from the Prospective International Forum-Trial

被引：0

作者：

Kalwak, Krzysztof ^{[1
]}

Bader, Peter ^{[2
]}

Dalle, Jean-Hugues ^{[3
]}

Sedlacek, Petr ^{[4
]}

Buechner, Jochen ^{[5
]}

Ifversen, Marianne ^{[6
]}

Svec, Peter ^{[7
]}

Stein, Jerry ^{[8
]}

Gungor, Tayfun ^{[9
]}

Toporski, Jacek ^{[10
]}

Diaz De Heredia, Cristina ^{[11
]}

Bierings, Marc

Meisel, Roland ^{[12
]}

Ansari, Marc ^{[13
]}

Balduzzi, Adriana ^{[14
,15
]}

Poetschger, Ulrike ^{[16
]}

Peters ^{[17
]}

Locatelli, Franco ^{[18
]}

机构：

[1] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland

[2] Univ Childrens Hosp Frankfurt, Frankfurt, Germany

[3] Univ Hosp Robert Debre, Assistance Publ Hop Paris APHP, Dept Pediat Hematol & Immunol, Paris, France

[4] Charles Univ Prague, Univ Hosp Motol, Dept Pediat Hematol Oncol, Prague, Czech Republic

[5] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway

[6] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark

[7] Comenius Univ, Natl Inst Childrens Dis, Dept Pediat Hematol & Oncol, Bone Marrow Transplantat Unit, Bratislava, Slovakia

[8] Schneider Childrens Med Ctr Israel, Dept Hematol Oncol, Petah Tiqwa, Israel

[9] Univ Childrens Hosp, Zurich, Switzerland

[10] Karolinska Univ, Tema Canc, ME Cellterapi Allogen Stamcellstransplantat CAST, Stockholm, Sweden

[11] Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, Barcelona, Spain

[12] Heinrich Heine Univ, Div Pediat Stem Cell Therapy, Dept Pediat Oncol Hematol & Clin Immunol, Med Fac, Dusseldorf, Germany

[13] Hop Univ Geneve, Geneva, Switzerland

[14] Fdn IRCCS San Gerardo de Tintori, Pediat Hematopoiet Transplant Unit, Monza, Italy

[15] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy

[16] St Anna Childrens Canc Res Inst CCRI, Vienna, Austria

[17] St Anna Childrens Hosp, Vienna, Austria

[18] Univ Cattolica Sacro Cuore, Dept Pediat, Rome, Italy

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180728

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 6 条

[1] Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Kalwak, Krzysztof
Moser, Laura M.
Poetschger, Ulrike
Bader, Peter
Kleinschmidt, Katharina
Meisel, Roland
Dalle, Jean-Hugues
Yesilipek, Akif
Balduzzi, Adriana
Krivan, Gergely
Goussetis, Evgenios
Staciuk, Raquel
Sedlacek, Petr
Pichler, Herbert
Svec, Peter
Gabriel, Melissa
Guengoer, Tayfun
Bilic, Ernest
Buechner, Jochen
Renard, Marleen
Vettenranta, Kim
Ifversen, Marianne
Diaz-de-Heredia, Cristina
Stein, Jerry
Toporski, Jacek
Bierings, Marc
Peters, Christina
Ansari, Marc
Locatelli, Franco
BLOOD ADVANCES, 2025, 9 (04) : 741 - 751
[2] THE RESULTS OF ALLOGENEIC HSCT AFTER TREOSULFAN-BASED CONDITIONING REGIMEN IN CHILDREN WITH AML: MULTICENTER RETROSPECTIVE STUDY OF THE POLISH PEDIATRIC STUDY GROUP FOR HSCT
Sobkowiak-Sobierajska, Agnieszka
Zajac-Spychala, Olga
Deregowski, Maksymilian
Mielcarek-Siedziuk, Monika
Kalwak, Krzysztof
Zaucha-Prazmo, Agnieszka
Drabko, Katarzyna
Debski, Robert
Styczynski, Jan
Gozdzik, Jolanta
Wachowiak, Jacek
BONE MARROW TRANSPLANTATION, 2024, 59 : 264 - 265
[3] Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial
Peters, Christina
Poetschger, Ulrike
Dalle, Jean-Hugues
Yesilipek, Akif
Stein, Jerry
Pichler, Herbert
Balduzzi, Adriana
Locatelli, Franco
Sedlacek, Petr
Wachowiak, Jacek
Gungor, Tayfun
Ifversen, Marianne
Renard, Marleen
Truong, Tony H.
Staciuk, Raquel
Shaw, Peter J.
Krivan, Gergely
Buchner, Jochen
Bader, Peter
BLOOD, 2022, 140
[4] LOW TOXICITY WITH MYELOABLATIVE CHEMO-BASED CONDITIONING FOR CHILDREN WITH ALL BELOW 4 YEARS OF AGE. RESULTS FROM THE PROSPECTIVE MULTINATIONAL FORUM-TRIAL
Peters, Christina
Poetschger, Ulrike
Dalle, Jean-Hugues
Yesilipek, Akif
Stein, Jerry
Pichler, Herbert
Balduzzi, Adriana
Locatelli, Franco
Sedlacek, Petr
Wachowiak, Jacek
Gungor, Tayfun
Ifversen, Marianne
Renard, Marleen
Truong, Tony H.
Staciuk, Raquel
Shaw, Peter J.
Krivan, Gergely
Buechner, Jochen
Bader, Peter
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 137 - 138
[5] Preliminary results of novel Treosulfan-based conditioning regimen for allogenic HSCT with TCRαβ/CD19 graft depletion in Nijmegen breakage syndrome after five years of Busulfan experience
Laberko, Alexandra
Gutovskaya, Elena
Radigina, Svetlana
Kozlovskaya, Svetlana
Shipitsina, Irina
Deripapa, Elena
Shcherbina, Anna
Maschan, Michael
Maschan, Alexei
Balashov, Dmitry
BONE MARROW TRANSPLANTATION, 2018, 53 : 531 - 531
[6] Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial
Locatelli, Franco
Bader, Peter
Dalle, Jean-Hugues
Poetschger, Ulrike
Pichler, Herbert
Sedlacek, Petr
Buchner, Jochen
Shaw, Peter J.
Ifversen, Marianne
Staciuk, Raquel
Vettenranta, Kim
Balduzzi, Adriana
Peters, Christina
BLOOD, 2022, 140 : 4865 - 4867

← 1 →